Oncology Central

Fertility preservation in cancer patients with a poor prognosis: the controversy of posthumous reproduction


For many cancer patients, dreams of genetically related children may be diminished after cancer treatments, which may compromise patients’ fertility. Systemic chemotherapy or radiation therapy may impact reproductive or endocrine functioning. These treatments may impact future fertility in several ways: gonadal damage; diminished reproductive function such as hormonal regulation; structural damage to organs such as the uterus, reducing the possibility of conception or carrying a pregnancy to term; and diminished erectile functioning that may impact the likelihood of natural conception. For many patients, especially those who desire genetically related children, cancer treatment related infertility may adversely affect quality of life and increase emotional distress [1]. Fertility preservation (FP) may address this concern by offering additional options for future parenting. FP preserves gametes using a range of assisted reproductive technology (ART) techniques, such as sperm and embryo cryopreservation.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.